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Introduction
Linear scleroderma “en coup de sabre” (ECDS) is a rare subset of localized 
scleroderma. Affected individuals typically have a characteristic atrophic skin 
lesion involving the fronto-parietal scalp. The disease usually has a benign course 
and has been distinguished in the past from systemic scleroderma by lack of 
significant internal organ involvement (1). However, on rare occasion evidence 
of organ involvement in linear scleroderma can be manifested as involvement of 
the rheumatologic, neurologic, and ophthalmologic systems (2). Additionally, 
rare neurologic symptoms can be seen associated with linear scleroderma. The 
most common neurologic symptom is epilepsy, but other neurologic deficits like 
movement disorders or behavioral changes have been reported (2). The presence 
of neurologic symptoms often heralds the existence of an intracranial abnormality; 
it is unusual for these patients to have a mass without the presence of neurological 
symptoms. 
Intracranial magnetic resonance imaging (MRI) findings seen in this group of 
patients commonly include: focal brain atrophy, calcifications and T2-hyperintense 
white matter lesions that may demonstrate contrast enhancement (2,3). 
Characteristically, white matter lesions and calcifications are found in the cerebral 
hemisphere ipsilateral to the skin abnormality. Although rare, infratentorial lesions 
and lesions located away from the skin manifestation have been reported in the 
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with methotrexate, demonstrated new patchy, large, 
confluent areas of T2 prolongation in the white matter 
of the left cerebellar hemisphere without significant 
mass effect. On diffusion weighted imaging (DWI) 
these parenchymal abnormalities showed increased 
diffusivity. Post contrast images demonstrated new 
scattered nodular foci of enhancement throughout 
these areas of parenchymal signal abnormality with 
corresponding susceptibility effect, most compatible 
with micro-hemorrhages (Figures 3A & 3B). The 
degree of leptomeningeal enhancement in the left 
cerebellar hemisphere had increased since the previous 
study (Figure 3C). 
The third and most recent brain MRI was performed 
at eight years of age (twelve months after the prior 
exam) and demonstrated continued increase in size 
of the confluent areas of T2 prolongation in the left 
cerebellar hemisphere (Figures 4A & 4B). Treatment 
with methotrexate had been discontinued three months 
prior to obtaining this most recent brain MRI. These 
lesions again demonstrated increased diffusivity on 
DWI (Figures 4C & 4D). Additionally, new areas 
of T2 prolongation were identified involving the 
cerebellar vermis and the medial aspect of the right 
cerebellar hemisphere. Post contrast images showed 
more confluent nodular parenchymal enhancement 
and persistent diffuse leptomeningeal enhancement 
(Figure 4E). Corresponding magnetic susceptibility on 
gradient-recalled echo (GRE) T2* was present within 
the nodular foci of enhancement (Figure 4F).
Discussion
Linear scleroderma “en coup de sabre” is a rare subset 
of localized scleroderma, a distinct and separate disease 
entity from systemic scleroderma (1). Localized 
scleroderma is also referred to as Morphea, and is 
differentiated from systemic sclerosis by the absence of 
sclerodactyly, Raynaud’s phenomenon, capillaroscopic 
abnormalities, and organ involvement. Localized 
scleroderma is a fibrosing condition characterized 
by thickening and hardening of the skin as a result of 
increased collagen production, with involvement of the 
subcutaneous tissue and underlying bone. Five clinical 
subtypes of localized scleroderma have been suggested: 
circumscribed, linear, generalized, pansclerotic, and 
literature (2,4,5). This report describes the case of a 
young boy with linear scleroderma ECDS, who was 
found to have a progressively enlarging cerebellar lesion 
on incidental MRI, in the absence of any neurological 
signs and symptoms.
Case Report
A 5-year-old boy was referred for routine brain MRI 
by the department of neurosurgery after presenting for 
consultation in the setting of his primary illness, linear 
scleroderma ECDS, affecting his left fronto-parietal 
scalp. The patient was initially diagnosed with linear 
scleroderma at that time on the basis of physical exam 
findings. The diagnosis was confirmed via a biopsy of 
his left fronto-parietal scalp. He subsequently received 
treatment with methotrexate weekly for 22 months. 
Prior to his diagnosis of linear scleroderma ECDS, the 
child had no other relevant past medical history. At the 
time of diagnosis, as well as at the time of the first MRI, 
the patient had no neurologic deficits or neurologic 
symptoms.
On physical examination, the patient had a band-like 
scalp lesion in the left upper fronto-parietal region 
consisting of a 7.5 x 2.5 cm atrophic, shiny, pink-white 
plaque with alopecia and hyperkeratosis. The patient was 
noted to have a smaller lesion of similar characteristics, 
anterior and inferior to the large plaque. Both the patient 
and his mother reported that these lesions had improved 
with initial treatment and had appeared stable in size 
since the discontinuation of the medication. 
Brain MRI was performed using a 1.5- T MR scanner 
(Signa HDx; GE Healthcare, Waukesha, WI, USA). At 
the time of diagnosis, imaging demonstrated a single, 
ill defined, non-enhancing, 10 x 4 mm focus of T2 
prolongation in the left cerebellar white matter (Figures 
1A & 1B). On post contrast images, there was mild 
diffuse leptomeningeal enhancement in the posterior 
aspect of the left cerebellar hemisphere (Figure 1C). 
Subsequently, a head CT scan demonstrated a focal 
area of scalp thinning within the left fronto-parietal 
region with associated flattening and thinning of the 
underlying frontal and parietal bones. There was no 
evidence of intracranial calcifications (Figure 2). 
A follow-up brain MRI was performed 14 months 
later, at age six, while the patient was on treatment 
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forehead, cutaneous manifestations may extend to the 
nose, cheek, chin, and neck. Facial atrophy occurs if 
the underlying muscle, cartilage and bone are involved. 
These clinical findings can overlap or coexist in ECDS 
and PFH making it difficult to classify them as separate 
entities (2,6).
In most reported cases of linear scleroderma in the 
literature, neurologic symptoms are usually preceded by 
the skin manifestations; however, neurologic symptoms 
can sometimes appear first. The range of neurologic 
symptoms associated with craniofacial scleroderma is 
variable. They include seizures, recent onset headaches, 
focal neurologic deficits and movement disorders which 
can be secondary to brain lesions, trigeminal neuralgia, 
masticatory spasms, mimics of hemiplegic migraines, 
behavioral changes, or progressive intellectual 
deterioration due to cerebral hemiatrophy either with 
or without focal seizures. Rarely, even death has been 
reported due to brainstem involvement (2,6). Epilepsy 
remains, however, the most common neurologic 
symptom associated with linear scleroderma (2). 
Typically, patients with linear scleroderma intracranial 
pathology, seen on neuroimaging studies will present with 
neurological symptoms. Uncommonly, asymptomatic 
patients may be found to have abnormal neuroimaging 
studies. Classic central nervous system findings on CT 
and MRI include brain parenchyma atrophy, white 
matter lesions, and focal subcortical calcifications. 
Parenchyma and leptomeningeal enhancement may 
also be seen (2,3). Neuroimaging findings are typically 
ispilateral to the skin lesions in the cerebral hemisphere. 
Rarely, contralateral and infratentorial involvement 
have been described (2,4,5). Calcifications typically 
involve the basal ganglia, thalami, and dentate nuclei, 
but can also be found in the subcortical white matter 
(2,7). MRI usually exhibits T2 hyperintensities, mostly 
in the subcortical white matter, but also in the corpus 
callosum, deep grey nuclei, and brain stem. Cerebral 
atrophy is generally focal and subtle, characterized by 
blurring of the gray-white interface, cortical thickening, 
and abnormal gyral pattern (2,3). Rarely, hippocampal 
atrophy has been reported (7).
The diagnosis of linear scleroderma is made based on the 
clinical characteristics of the cutaneous and soft tissue 
findings. There are no laboratory tests diagnostic for 
mixed (1). Linear scleroderma is the most common 
subtype in children and has three clinical variants: 
linear limb involvement, “en coup de sabre” (ECDS), 
and progressive hemifacial atrophy (Parry- Romberg 
syndrome) (1,6). 
Underlying tissue atrophy is commonly present in 
these three variants. ECDS is defined by a unilateral 
band of sclerotic skin lesions in the fronto-parietal 
area of the head resembling a deep saber wound, hence 
the name “en coup de sabre” (meaning, the saber cut 
in French). ECDS can be associated with ipsilateral 
underlying intracranial lesions and ocular involvement 
(1). Progressive hemifacial atrophy (PFH) consists of 
atrophy which extends below the skin and subcutaneous 
tissues, and often involves underlying muscle and 
bone (2). Several authors have postulated that ECDS 
and progressive hemifacial atrophy (PHA) may be 
clinical variants of the same disease (1-3,6).  These two 
entities can coexist and share similarities including a 
comparable age of onset, female predominance, identical 
neurologic and ophthalmologic complications, and the 
same neuroimaging characteristics. Both diseases may 
respond to immunosuppressive treatment (2).
The incidence of localized scleroderma has been 
reported as 0.4 to 2.7 per 100,000 people (1), with a 
female predominance (6), and increased prevalence in 
the white population (1). The prevalence of localized 
scleroderma seems to be equal in adults and children. A 
large, multicenter, multinational study reported a mean 
age at disease onset of 7.3 years (range 0 – 16 years). 
The mean time between the first manifestation of the 
disease and diagnosis was 1.6 years, with a median of 
eleven months (range 0 – 16.7 years) (6). 
The skin lesions of localized scleroderma (Morphea) 
are a characteristic clinical finding which undergo an 
initial inflammatory stage of erythematous, dusky, 
violaceous patches or plaques. Later, the center of the 
lesion becomes white and sclerotic, with a surrounding 
outer “violaceous ring”. Once the active phase resolves, 
the skin lesion turns into a near completely white 
sclerotic plaque with subsequent post-inflammatory 
hyperpigmentation. Excessive collagen deposition 
destroys hair follicles and adnexal structures, resulting 
in hairless, anhidrotic plaques (1). Aside from alopecia 
in a band-like fashion in the fronto-parietal scalp and 
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linear scleroderma, although, patients may be positive 
for anti-nuclear antibodies (ANA), anti-single-stranded-
DNA antibodies (anti-ssDNA) and rheumatoid factor 
(2,6). Histopathologic examination cannot differentiate 
localized scleroderma from systemic sclerosis. In the 
early stage both entities have lymphocytic perivascular 
infiltration in the reticular dermis and swollen 
endothelial cells. Late stages of disease show thickened 
collagen bundles infiltrating the dermis and extending 
into the subcutaneous fat (1).
The etiology of linear scleroderma is not well 
understood; however, there is evidence suggesting 
an autoimmune origin of this disease (2). Early in the 
disease course, damage to the endothelial cells results in 
increased vascular permeability with mononuclear cell 
infiltration, perivascular inflammatory cell infiltrates, 
vascular intimal thickening, and vessel narrowing. These 
vessels gradually lose their elasticity, and the media and 
adventitia become fibrotic (8). Pathogenesis of CNS 
disease suggests perivascular infiltrate and vasculitis, 
but is limited, as biopsies are not routinely done. In a 
few reported cases, histological findings include gliosis, 
leptomeningeal band-like sclerosis, thickened blood 
vessel walls, and intraparenchymal calcifications, all 
of which suggests a chronic inflammatory process (8). 
Environmental factors have been reported occurring 
close to the disease onset, including mechanical factors, 
infections, drugs and psychological distress (6). 
This case is unique in that the patient‘s CNS 
manifestations were not located in the cerebrum 
underlying the skin lesion, but were infratentorial in the 
contralateral cerebellar hemisphere. More interestingly 
however, the patient in this case did not manifest 
with any neurologic symptoms despite the fact that 
he had progression of his intracranial pathology over 
the span of several years. In rare cases of cerebellar 
involvement, the disease usually manifests as atrophy 
and volume loss. On the contrary, our patient presented 
with infiltrative appearing lesions that exerted mild 
mass effect on the fourth ventricle. Furthermore, 
despite immunosuppressive treatment, these white 
matter cerebellar lesions increased in size considerably 
during a 2-year period. In the absence of the patient‘s 
history one could easily confuse the findings with 
infiltrating tumor. However, it would be unlikely for a 
primary CNS neoplasm to present initially with mainly 
leptomeningeal enhancement. Several of the lesions 
demonstrated nodular enhancement on post contrast 
T1-weighted images with corresponding magnetic 
susceptibility, suggesting injured vascular wall with 
presence of micro-hemorrhages. The parenchymal 
lesions demonstrated increased diffusivity most likely 
consistent with insterstitial edema.  The constellation of 
neuroimaging findings seen in this case are suggestive 
of cerebral vasculopathy, classically seen as part of 
other autoimmune processes. 
Despite progression of neuroimaging findings and given 
that the patient had a normal clinical exam with absence 
of neurologic symptoms, a conservative approach was 
preferred and biopsy of the cerebellar lesion was not 
performed. A period of observation was suggested to 
the patient, whose family was agreeable, and he has not 
had any neurological manifestations to date.  
In conclusion, typical neuroimaging features of linear 
scleroderma including atrophy, white matter lesions and 
calcifications typically involve the cerebral hemisphere 
ipsilateral to the skin lesion. However, CNS lesions 
can also present away from the skin lesion in the 
cerebellar hemisphere with imaging features similar to a 
demyelinating process or infiltrating tumors, as opposed 
to the more common presentation of parenchymal 
atrophy. It is important to recognize that even in the 
absence of neurological symptoms, patients with linear 
scleroderma may present with atypical neuroimaging 
features found on routine imaging which should not be 
mistaken for an infiltrating neoplasm.
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Fig  2. Coronal 2-D reformatted CT image with contrast demonstrates focal scalp thinning within 
the left fronto-parietal region and thinning of the underlying frontal and parietal bones.
Atypical Neuroimaging Manifestations of Linear Scleroderma “en coup de sabre”
 
hemisphe
opposed 
that even
with atyp
an infiltra
Acknowl
This wor
Boston C
funding a
presented
Authors
the prepa
 
 
 
re with ima
to the more 
 in the absen
ical neuroim
ting neopla
edgement: 
k was perfor
hildren’s H
nd the autho
 at any mee
’ Contribut
ration of thi
ging feature
common pre
ce of neuro
aging featu
sm. 
med at the B
ospital (Bos
rs have no 
ting. 
ions: All au
s manuscrip
s similar to 
sentation of
logical symp
res found on
righam and
ton, MA, US
financial rel
thors have c
t. All author
a demyelina
 parenchym
toms, patie
 routine im
 Women’s H
A). The wo
ationships to
ontributed e
s agree with
ting process
al atrophy. 
nts with line
aging which
ospital (Bo
rk was not s
 disclose. T
qually to th
 its content
 or infiltrati
It is importa
ar scleroder
 should not 
ston, MA, U
upported by
he work has
e care of thi
. 
ng tumors, a
nt to recogn
ma may pre
be mistaken
SA) and th
 any source
 not been 
s patient and
10 
s 
ize 
sent 
 for 
e 
s of 
 to 
 
 Fig 1. Initial brain MRI exam. (A) Axial T2-weighted image, (B) axial FLAIR image showing subtle 10 x 4 mm 
focus of T2 prolongation in the white matter of the left cerebellar hemisphere and (C) mild diffuse leptomeningeal 
enhancement was present overlying the left posterior cerebellar hemisphere.
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 Fig 3. Repeat MRI fourteen months later. (A) Axial T2-weighted image, (B) axial FLAIR image 
showing new, extensive, patchy areas of T2 prolongation in the white matter of the left cerebellar 
hemisphere and (C) post contrast axial T1-weighted image demonstrating persistent mild diffuse 
leptomeningeal enhancement (small arrow) with new areas of nodular parenchymal enhancement 
(large arrow) in the left cerebellar hemisphere.
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Fig 4. Third MRI at age eight. (A) Axial T2- weighted image, (B) axial FLAIR image showing continued increase 
in size of the patchy areas of T2 prolongation in the left cerebellar hemisphere, (C) axial diffusion weighted image, 
(D) axial ADC map show corresponding increased diffusivity of the parenchymal lesions, (E) small foci of increased 
magnetic susceptibility on GRE T2* images are present and (F) post contrast axial T1-weighted image showing 
persistent leptomeningeal enhancement with more confluent nodular parenchymal enhancement. 
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